Centiva Capital LP Invests $542,000 in Encompass Health Co. (NYSE:EHC)

Centiva Capital LP bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 5,868 shares of the company's stock, valued at approximately $542,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in EHC. Miracle Mile Advisors LLC lifted its holdings in shares of Encompass Health by 3.0% during the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company's stock valued at $354,000 after purchasing an additional 112 shares in the last quarter. US Bancorp DE increased its position in shares of Encompass Health by 9.6% during the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock worth $127,000 after purchasing an additional 121 shares during the last quarter. Signaturefd LLC increased its position in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after purchasing an additional 125 shares during the last quarter. CBIZ Investment Advisory Services LLC increased its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its holdings in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares during the last quarter. Institutional investors own 97.25% of the company's stock.

Insider Transactions at Encompass Health

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the sale, the insider now owns 11,958 shares in the company, valued at $1,394,422.38. This trade represents a 26.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president now directly owns 79,710 shares of the company's stock, valued at approximately $9,149,910.90. The trade was a 11.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.00% of the company's stock.

Encompass Health Trading Down 0.4%

Shares of Encompass Health stock traded down $0.53 during trading on Thursday, reaching $118.75. The company's stock had a trading volume of 364,692 shares, compared to its average volume of 689,196. The firm's 50-day moving average is $104.54 and its two-hundred day moving average is $100.41. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 52-week low of $82.74 and a 52-week high of $120.11. The company has a market cap of $11.97 billion, a price-to-earnings ratio of 26.59, a PEG ratio of 2.31 and a beta of 0.91.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The company's revenue for the quarter was up 10.6% on a year-over-year basis. During the same period in the prior year, the business earned $1.12 EPS. On average, sell-side analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.57%. The ex-dividend date is Tuesday, July 1st. Encompass Health's dividend payout ratio (DPR) is 14.05%.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Barclays upped their price objective on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday, April 25th. UBS Group upped their price objective on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Truist Financial reaffirmed a "buy" rating and issued a $135.00 target price (up previously from $116.00) on shares of Encompass Health in a report on Monday, April 28th. William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, KeyCorp lifted their target price on shares of Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. Nine research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $120.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.